Sleeve gastrectomy and Roux En Y gastric bypass: current state of metabolic surgery.
about
Postoperative effects of laparoscopic sleeve gastrectomy in morbid obese patients with type 2 diabetes.Weight-loss outcomes of SPIDER(®) sleeve gastrectomy at 6 months compared to traditional laparoscopic technique.Pathophysiology and Potential Non-Pharmacologic Treatments of Obesity or Kidney Disease Associated Refractory Hypertension.Significant Liver-Related Morbidity After Bariatric Surgery and Its Reversal-a Case Series.Association of Bariatric Surgery Using Laparoscopic Banding, Roux-en-Y Gastric Bypass, or Laparoscopic Sleeve Gastrectomy vs Usual Care Obesity Management With All-Cause Mortality.
P2860
Sleeve gastrectomy and Roux En Y gastric bypass: current state of metabolic surgery.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Sleeve gastrectomy and Roux En Y gastric bypass: current state of metabolic surgery.
@en
type
label
Sleeve gastrectomy and Roux En Y gastric bypass: current state of metabolic surgery.
@en
prefLabel
Sleeve gastrectomy and Roux En Y gastric bypass: current state of metabolic surgery.
@en
P2093
P1476
Sleeve gastrectomy and Roux En Y gastric bypass: current state of metabolic surgery.
@en
P2093
Angela Osmolak
Robert Armour Forse
Zachary Torgersen
P304
P356
10.1097/MED.0000000000000099
P577
2014-10-01T00:00:00Z